[go: up one dir, main page]

ES2176197T3 - Sistema de administracion transdermal que contiene un acido acetilsalicilico para la terapia de trombosis y la profilaxis del cancer. - Google Patents

Sistema de administracion transdermal que contiene un acido acetilsalicilico para la terapia de trombosis y la profilaxis del cancer.

Info

Publication number
ES2176197T3
ES2176197T3 ES93900057T ES93900057T ES2176197T3 ES 2176197 T3 ES2176197 T3 ES 2176197T3 ES 93900057 T ES93900057 T ES 93900057T ES 93900057 T ES93900057 T ES 93900057T ES 2176197 T3 ES2176197 T3 ES 2176197T3
Authority
ES
Spain
Prior art keywords
profilaxis
cancer
transdermal administration
administration system
system containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93900057T
Other languages
English (en)
Inventor
Frank Becher
Thomas Kissel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2176197T3 publication Critical patent/ES2176197T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN SISTEMA DE ADMINISTRACION TRANSDERMAL PARA LA TERAPIA DE TROMBOSIS Y LA PROFILAXIS DEL CANCER, CONTENIENDO EL SISTEMA COMO SUSTANCIA ACTIVA ACIDO ACETILSALICILICO Y/O SALES ACEPTABLES FARMACEUTICAMENTE DEL ACIDO ACETILSALICILICO.
ES93900057T 1991-12-20 1992-12-16 Sistema de administracion transdermal que contiene un acido acetilsalicilico para la terapia de trombosis y la profilaxis del cancer. Expired - Lifetime ES2176197T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4142483 1991-12-20

Publications (1)

Publication Number Publication Date
ES2176197T3 true ES2176197T3 (es) 2002-12-01

Family

ID=6447817

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93900057T Expired - Lifetime ES2176197T3 (es) 1991-12-20 1992-12-16 Sistema de administracion transdermal que contiene un acido acetilsalicilico para la terapia de trombosis y la profilaxis del cancer.

Country Status (23)

Country Link
US (2) US6264978B1 (es)
EP (1) EP0617623B1 (es)
JP (1) JP3748270B2 (es)
KR (2) KR100267442B1 (es)
AT (1) ATE217528T1 (es)
AU (1) AU667067B2 (es)
CA (1) CA2125662C (es)
CZ (1) CZ285190B6 (es)
DE (2) DE4241128C2 (es)
DK (1) DK0617623T3 (es)
ES (1) ES2176197T3 (es)
FI (1) FI113838B (es)
HR (1) HRP921157A2 (es)
HU (1) HU221679B1 (es)
IL (1) IL103917A (es)
NO (1) NO306599B1 (es)
NZ (1) NZ246158A (es)
PT (1) PT617623E (es)
SI (1) SI9200312A (es)
SK (1) SK67094A3 (es)
WO (1) WO1993012799A1 (es)
YU (1) YU75093A (es)
ZA (1) ZA922814B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
WO1994013302A1 (de) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
JP3799502B2 (ja) * 1992-12-07 2006-07-19 エル テー エス ローマン テラピー・システーメゲー．エム．ベー．ハー ウント コンパニー カー．ゲー 抗血栓治療および癌予防のためのアセチルサリチル酸を含有する経皮投与システム
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
WO1997004757A1 (en) * 1995-07-27 1997-02-13 Cal International Limited Transdermal nitrate formulation
WO1997004759A1 (en) * 1995-07-27 1997-02-13 Cal International Limited Transdermal patch containing aspirin
AU6709096A (en) * 1995-07-27 1997-02-26 Cal International Limited Pharmaceutical preparation for percutaneous absorbtion
EP0784975B1 (en) * 1995-12-26 2005-10-19 Teikoku Seiyaku Kabushiki Kaisha Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
DE19601487C2 (de) * 1996-01-17 2001-09-13 Micronas Gmbh Vorrichtung zum Behandeln von malignen Gewebsveränderungen
JPH1112177A (ja) 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
JP2001187739A (ja) * 1999-12-28 2001-07-10 Teikoku Seiyaku Co Ltd アレルギー性皮膚疾患治療用外用剤
RU2201234C2 (ru) * 2000-12-05 2003-03-27 Воронежский государственный университет Полимерный водорастворимый аналог ацетилсалициловой кислоты и способ его получения
WO2003018023A1 (en) * 2001-08-23 2003-03-06 Bruce Frome Compositions and methods for targeting cerebral circulation and treatment of headache
US20040248858A1 (en) * 2003-06-09 2004-12-09 Parghi Kaumil H. Cure for cancer
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
EP2610242A1 (en) 2006-07-09 2013-07-03 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
JP2010526945A (ja) * 2007-05-09 2010-08-05 バックマン・ラボラトリーズ・インターナショナル・インコーポレーテッド 紙及び板紙用のａｓａサイジングエマルジョン
CN105820107B (zh) 2007-06-04 2022-09-09 泰飞尔公司 具有快速皮肤和生物膜穿透速度的非甾体抗炎药的前药及其新的医药用途
RU2630577C2 (ru) 2008-12-04 2017-09-11 Чунси ЮЙ Композиции интенсивного проникновения и их применение
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
KR102332837B1 (ko) 2012-01-18 2021-12-01 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
FR2297612A1 (fr) 1975-01-20 1976-08-13 Moorleghem Guy Van Procede de fabrication d'un produit analgesique a usage externe
US4012508A (en) 1975-02-03 1977-03-15 Burton Verna M Topical composition and method
US4219548A (en) 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
FR2496459A1 (fr) 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
IL68965A (en) 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4640689A (en) 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
EP0162239B1 (en) 1984-04-23 1991-08-07 Kao Corporation Percutaneous absorption accelerator and preparation containing same
JPS61167615A (ja) 1985-01-18 1986-07-29 Teisan Seiyaku Kk 薬剤投与方法
US4810699A (en) 1987-02-20 1989-03-07 American Home Products Corporation Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
JPH01203336A (ja) 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
JPH01242521A (ja) 1988-03-23 1989-09-27 Nikko Kemikaruzu Kk 経皮吸収性を高めた消炎鎮痛薬組成物
US4975269A (en) 1989-07-31 1990-12-04 Leonard Chavkin Shelf stable aspirin solutions
EP0578780B1 (en) 1991-04-03 2003-07-02 Keimowitz, Rudolph, M.D. Suppression of thromboxane levels by percutaneous administration of aspirin

Also Published As

Publication number Publication date
DK0617623T3 (da) 2002-09-09
IL103917A (en) 1996-09-12
AU3158993A (en) 1993-07-28
FI113838B (fi) 2004-06-30
IL103917A0 (en) 1993-04-04
YU75093A (sh) 1997-08-22
KR100267359B1 (ko) 2000-11-01
NO942325D0 (no) 1994-06-17
FI942922A0 (fi) 1994-06-17
SI9200312A (en) 1993-06-30
NO942325L (no) 1994-06-17
FI942922L (fi) 1994-06-17
US6264978B1 (en) 2001-07-24
KR100267442B1 (ko) 2000-11-01
ATE217528T1 (de) 2002-06-15
DE4241128C2 (de) 1996-05-23
CZ145694A3 (en) 1995-01-18
KR950703972A (ko) 1995-11-17
DE4241128A1 (en) 1993-06-24
AU667067B2 (en) 1996-03-07
DE59209956D1 (de) 2002-06-20
HU221679B1 (hu) 2002-12-28
NZ246158A (en) 1995-10-26
JPH07502521A (ja) 1995-03-16
HU9401849D0 (en) 1994-09-28
JP3748270B2 (ja) 2006-02-22
EP0617623B1 (de) 2002-05-15
ZA922814B (en) 1993-06-23
NO306599B1 (no) 1999-11-29
EP0617623A1 (de) 1994-10-05
US5861170A (en) 1999-01-19
PT617623E (pt) 2002-10-31
CA2125662A1 (en) 1993-07-08
CA2125662C (en) 2006-10-17
HUT74559A (en) 1997-01-28
CZ285190B6 (cs) 1999-06-16
SK67094A3 (en) 1995-03-08
HRP921157A2 (en) 1994-10-31
WO1993012799A1 (de) 1993-07-08

Similar Documents

Publication Publication Date Title
ES2176197T3 (es) Sistema de administracion transdermal que contiene un acido acetilsalicilico para la terapia de trombosis y la profilaxis del cancer.
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
ES2188586T3 (es) Utilizacion de inhibidores del complemento para la preparacion de un medicamento para la profilaxis y terapia de enfermedades inflamatorias intestinales y de la piel, asi como purpura.
ES2173868T3 (es) Utilizacion de relaxina para la fabricacion de un medicamento destinado al tratamiento de enfermedades cardiovasculares.
ES2132105T3 (es) 2-aminometil-cromanos como principios activos en farmacos para el tratamiento de enfermedades del sistema nervioso central.
ES2092113T3 (es) Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno.
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
ES2164182T3 (es) Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana.
MX9304819A (es) Nuevos derivados de xantina y procedimiento para su preparacion.
UY26456A1 (es) Compuestos que fijan la estructura g-cuadruplex de los telomeros, triazinas de aplicación de dichos compuestos, la utilización de dichos compuestos como productos farmacéuticos y las asociaciones terapéuticas que los incluyen.
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
ES8707513A1 (es) Procedimiento para preparar nuevos tetrahidro-benzotiazoles.
CO4770978A1 (es) Empleo de epinastina para el tratamiento de dolores
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
ES2136725T3 (es) Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo.
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
ES2157422T3 (es) Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos.
ES2045009T3 (es) El acido taurohyodesoxicolico para la terapia de calculosis del tracto biliar y de la dispepsia biliar.
MX9601368A (es) Metodo de tratamiento de la reestenosis por terapia genica.
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
ES2082029T3 (es) Conjugados de acido difluoroglutamico con foliatos y antifoliatos para el tratamiento de enfermedades neoplasticas.
ES2094522T3 (es) Utilizacion de la creatinina fosfato o del acido fosfoenol piruvico para el tratamiento de los tumores.
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
ES2031376T3 (es) Procedimiento para la preparacion de cloruro ferrico a partir de cloruro ferroso.